ZR2 Bioenergy has informed that the Board of Directors of the Company at its meeting held on Thursday, May 29, 2025, has considered and approved the following: Approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2025, along with the Statement of Assets and Liabilities and Statement of Cash Flow; Took note of the Auditor’s Report with unmodified opinion on the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on March 31, 2025, issued by Statutory Auditors of the Company and the same is enclosed; A declaration signed by Managing Director of the Company with respect to the Auditor’s Report issued by the Statutory Auditor with unmodified opinion on the above-mentioned Audited Standalone and Consolidated Financial Results is also enclosed herewith. Furthermore, the extract of the Audited Standalone and Consolidated Financial Results of the Company for the financial year ended on March 31, 2025 will be published in the newspapers in compliance with the Regulation 47 of the Listing Regulations, along with Quick Response (QR) code and a webpage link where the complete financial results can be accessed; Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the year ended March 31, 2025; To take on record Monitoring Agency Report for the quarter ended March 31, 2025.
The above information is a part of company’s filings submitted to BSE.
